79 related articles for article (PubMed ID: 26505385)
21. Structural Insights into BET Client Recognition of Endometrial and Prostate Cancer-Associated SPOP Mutants.
Ostertag MS; Hutwelker W; Plettenburg O; Sattler M; Popowicz GM
J Mol Biol; 2019 May; 431(11):2213-2221. PubMed ID: 31026449
[TBL] [Abstract][Full Text] [Related]
22. Identification of speckle-type POZ protein somatic mutations in African American prostate cancer.
Buckles E; Qian C; Tadros A; Majumdar S; Cvitanovic J; Zabaleta J; Estrada J; Wilson J; Liu W
Asian J Androl; 2014; 16(6):829-32. PubMed ID: 24994784
[TBL] [Abstract][Full Text] [Related]
23. Mutational analysis of BRCA1/2 gene and pathologic characteristics from Kazakh population with sporadic breast cancer in northwestern China.
Yang SY; Aisimutula D; Li HF; Hu Y; Du X; Li J; Luan MX
Genet Mol Res; 2015 Oct; 14(4):13151-61. PubMed ID: 26535628
[TBL] [Abstract][Full Text] [Related]
24. The use of FNA samples for whole-exome sequencing and detection of somatic mutations in breast cancer surgical specimens.
Lee HB; Joung JG; Kim J; Lee KM; Ryu HS; Lee HO; Moon HG; Park WY; Noh DY; Han W
Cancer Cytopathol; 2015 Nov; 123(11):669-77. PubMed ID: 26265110
[TBL] [Abstract][Full Text] [Related]
25. The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2009 Apr; 114(3):457-62. PubMed ID: 18446436
[TBL] [Abstract][Full Text] [Related]
26. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
[TBL] [Abstract][Full Text] [Related]
27. [Identification of speckle type BTB/POZ protein mutation regulated key metabolic pathways by cell based proteomics and metabolomics].
Yan M; Liu J; Xia T; Xu G; Piao H
Se Pu; 2019 Aug; 37(8):887-896. PubMed ID: 31642260
[TBL] [Abstract][Full Text] [Related]
28. Hidden tricks in MATH: Hypermorphic mutations in SPOP tumor suppressor explained by cryo-EM.
Orme JJ; Mer G; Huang H
Mol Cell; 2023 Mar; 83(5):655-656. PubMed ID: 36868187
[TBL] [Abstract][Full Text] [Related]
29. SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression.
Zhang J; Chen M; Zhu Y; Dai X; Dang F; Ren J; Ren S; Shulga YV; Beca F; Gan W; Wu F; Lin YM; Zhou X; DeCaprio JA; Beck AH; Lu KP; Huang J; Zhao C; Sun Y; Gao X; Pandolfi PP; Wei W
Dev Cell; 2019 Feb; 48(3):329-344.e5. PubMed ID: 30595538
[TBL] [Abstract][Full Text] [Related]
30. Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland.
Cybulski C; Lubiński J; Wokołorczyk D; Kuźniak W; Kashyap A; Sopik V; Huzarski T; Gronwald J; Byrski T; Szwiec M; Jakubowska A; Górski B; Dębniak T; Narod SA; Akbari MR
Clin Genet; 2015 Oct; 88(4):366-70. PubMed ID: 25330149
[TBL] [Abstract][Full Text] [Related]
31. A recurrent mutation in PALB2 in Finnish cancer families.
Erkko H; Xia B; Nikkilä J; Schleutker J; Syrjäkoski K; Mannermaa A; Kallioniemi A; Pylkäs K; Karppinen SM; Rapakko K; Miron A; Sheng Q; Li G; Mattila H; Bell DW; Haber DA; Grip M; Reiman M; Jukkola-Vuorinen A; Mustonen A; Kere J; Aaltonen LA; Kosma VM; Kataja V; Soini Y; Drapkin RI; Livingston DM; Winqvist R
Nature; 2007 Mar; 446(7133):316-9. PubMed ID: 17287723
[TBL] [Abstract][Full Text] [Related]
32. Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.
Cajuso T; Hänninen UA; Kondelin J; Gylfe AE; Tanskanen T; Katainen R; Pitkänen E; Ristolainen H; Kaasinen E; Taipale M; Taipale J; Böhm J; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P
Int J Cancer; 2014 Aug; 135(3):611-23. PubMed ID: 24382590
[TBL] [Abstract][Full Text] [Related]
33. Contribution of mutations in ATM to breast cancer development in the Czech population.
Soukupova J; Dundr P; Kleibl Z; Pohlreich P
Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
[TBL] [Abstract][Full Text] [Related]
34. PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations.
Kim JH; Choi DH; Cho DY; Ahn SH; Son BH; Haffty BG
Breast Cancer Res Treat; 2010 Jul; 122(1):303-6. PubMed ID: 20213081
[TBL] [Abstract][Full Text] [Related]
35. Germline 657del5 mutation in the NBS1 gene in breast cancer patients.
Górski B; Debniak T; Masojć B; Mierzejewski M; Medrek K; Cybulski C; Jakubowska A; Kurzawski G; Chosia M; Scott R; Lubiński J
Int J Cancer; 2003 Sep; 106(3):379-81. PubMed ID: 12845677
[TBL] [Abstract][Full Text] [Related]
36. Mutation analysis of PALB2 gene in French breast cancer families.
Damiola F; Schultz I; Barjhoux L; Sornin V; Dondon MG; Eon-Marchais S; Marcou M; ; Caron O; Gauthier-Villars M; de Pauw A; Luporsi E; Berthet P; Delnatte C; Bonadona V; Maugard C; Pujol P; Lasset C; Longy M; Bignon YJ; Fricker JP; Andrieu N; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Muller D
Breast Cancer Res Treat; 2015 Dec; 154(3):463-71. PubMed ID: 26564480
[TBL] [Abstract][Full Text] [Related]
37. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.
Couch FJ; DeShano ML; Blackwood MA; Calzone K; Stopfer J; Campeau L; Ganguly A; Rebbeck T; Weber BL
N Engl J Med; 1997 May; 336(20):1409-15. PubMed ID: 9145677
[TBL] [Abstract][Full Text] [Related]
38. Comparative genomic analysis reveals bilateral breast cancers are genetically independent.
Song F; Li X; Song F; Zhao Y; Li H; Zheng H; Gao Z; Wang J; Zhang W; Chen K
Oncotarget; 2015 Oct; 6(31):31820-9. PubMed ID: 26378809
[TBL] [Abstract][Full Text] [Related]
39. Nabais Sa-de Vries syndrome in a Chinese infant associated with a novel SPOP mutation: A clinical study and genetic report.
Hu W; Fang H; Peng Y; Li L; Liu S; Liao H; Tang J; Yi J; Liu Q; Xu L; Wu L
Mol Genet Genomic Med; 2022 Dec; 10(12):e2075. PubMed ID: 36259278
[TBL] [Abstract][Full Text] [Related]
40. Nijmegen Breakage Syndrome mutations and risk of breast cancer.
Bogdanova N; Feshchenko S; Schürmann P; Waltes R; Wieland B; Hillemanns P; Rogov YI; Dammann O; Bremer M; Karstens JH; Sohn C; Varon R; Dörk T
Int J Cancer; 2008 Feb; 122(4):802-6. PubMed ID: 17957789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]